Alterations of [3H]Forskolin Binding in the Postischemic Rat Brain

開始ページ、終了ページ: 冊子体のページ付

Development of a New in vivo Double Autoradiogram for the Analysis of Dopaminergic System of the Rat Brain

開始ページ、終了ページ: 冊子体のページ付

Alterations of Second Messenger and Neurotransmitter Receptor Systems in the Exo-Focal Postischemic Brain Areas of the Rat: In vitro Autoradiographic Study

開始ページ、終了ページ: 冊子体のページ付

Effect of Mergocriptine on Ischemia-induced Brain Damages

開始ページ、終了ページ: 冊子体のページ付

Alterations in Neurotransmitter-Receptor and Second-Messenger System Binding in the Gerbil Hippocampus Following Repeated Ischemic Insults

開始ページ、終了ページ: 冊子体のページ付

Postischemic Changes of Spirodecanone Binding in the Gerbil Hippocampus

開始ページ、終了ページ: 冊子体のページ付

Exo-Focal Postischemic Neuronal Death in the Rat Brain

開始ページ、終了ページ: 冊子体のページ付

Inhibitory effect of ferulic acid and isoferulic acid on the production of macrophage inflammatory protein-2 in response to respiratory syncytial virus infection in RAW264.7 cells.

We investigated the effect of ferulic acid (FA) and isoferulic acid (IFA), which are the main active components of the rhizoma of Cimicifuga heracleifolia (CH), an anti-inflammatory drug used frequently in Japanese traditional medicine, on the production of macrophage inflammatory protein-2 (MIR-2) in a murine macrophage cell line, RAW264.7, in response to respiratory syncytial virus (RSV) infection. Following the exposure of cells to RSV for 20h, the MIP-2 level in condition medium was increased to about 20 ng/ml, although this level in mock-infected cells was negligible. In the presence of either FA or IFA, RSV-infected cells reduced MIP-2 production in a dose-dependent manner. These data suggest that FA and IFA might be responsible, at least in part, for the anti-inflammatory drug effect of CH extract through the inhibition of MIP-2 production

Administration of isoferulic acid improved the survival rate of lethal influenza virus pneumonia in mice.

BACKGROUND: Isoferulic acid (IFA) is a main active ingredient of the rhizoma of Cimicifuga beracleifolia, which is used frequently in Japanese traditional medicine as an anti-inflammatory drug. It has been revealed that IFA inhibits the production of macrophage inflammatory protein-2 (MIP-2), which is a murine counterpart of the chemokine family that may contribute to the pathogenesis of inflammatory diseases through the chemotactic activity for inflammatory and immune effector cells. AIM OF THE STUDY: In this study, we investigated the therapeutic effect of IFA on the progression of lethal influenza virus pneumonia in mice by comparison with that of dexamethasone (DX), a potent inhibitor for various inflammatory cytokines including MIP-2. METHODS: Mice were infected by intranasal inoculation of influenza virus under ether anesthesia. The IFA or DX was given by oral administration once daily for 4 days after infection. After infection, the survival rate and the change in body weight were daily monitored. RESULTS: IFA administration markedly improved the survival rate and body weight loss of influenza virus-infected mice in a suitable dose range (0.5 mg/day). However, DX administration did not show a beneficial effect at any dose. CONCLUSION: These data suggested that IFA is a novel tool not only for the intervention therapy, but also for the studies on the pathogenesis of influenza virus-induced pneumonia